European organisations join forces to shine spotlight on cardiovascular health
Rochester, UK, 27 September 2021: The European Alliance for Cardiovascular Health launches today to raise awareness of the burden of cardiovascular disease (CVD) and call for action from European decision-makers.
The announcement comes ahead of World Heart Day on 29 September.
CVD is a group of conditions affecting the heart or blood vessels – they prominently include heart attacks and strokes, as well as arrhythmias and congenital heart disease. CVD is closely interlinked with other chronic diseases, such as diabetes or kidney disease, but also vascular dementia which is often caused by heart disease and stroke.
CVD is the leading cause of death worldwide. In 2019, an estimated 17.9 million people died from CVD, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. CVD is also the leading cause of death in the European region, accounting for 47% of all deaths in women and 39% in men.
In the EU, CVD accounts for 36% of all deaths and impacts the lives of some 60 million people who live with cardiovascular conditions. CVD is not limited to the elderly, but heavily impacts people of all ages. Around 20% of all premature deaths (before the age of 65) in the EU are caused by CVD .
To ensure that Europe’s strategy for tackling CVD matches the scale of this collective challenge, the Alliance brings together, for the first time ever, 15 leading European and international organisations representing the full range of health actors. Together they offer an extraordinary wealth of knowledge in cardiovascular health.
Collectively, the Alliance represents:
- tens of millions of patients.
- more than 200,000 health professionals.
- over 400 health technology companies.
- health insurers covering the medical costs of more than 200 million people.
- millions of people living with genetic CVD risk factors but who have not been diagnosed yet.
The Alliance’s partners are committed to joining forces and sharing expertise to:
- raise awareness of the burden of CVD on society.
- call for a European CVD Plan to improve cardiovascular health, optimise quality of life in patients and undiagnosed citizens with CVD, and prevent first and subsequent heart events and strokes.
- advise policymakers on actions to improve cardiovascular health and to prevent CVD in Europe, thereby making the population more resilient to future pandemics and other health threats.
- mobilise investment for CVD research and promote public-private partnerships in CVD innovation.
- ensure swift and equitable access to new medical technologies and medicines that add value to patients and society.
In its first meeting today, information on the European Alliance for Cardiovascular Health is complemented by personal stories from patients about living with heart disease and stroke, giving insights into the needs of those with CVD and thus setting the European policy agenda. Policy debates follow, with EU decision-makers giving feedback on the Alliance’s proposals and paving the way for a constructive and forward-looking collaboration.
Jouzas Olekas, MEP Heart Group Supporter said: “The EU must act decisively to improve the cardiovascular health of European citizens and to create a strong as well as holistic European Health Union. Now is the time to tackle the increasing burden of cardiovascular disease and ensure that everyone can live longer, healthier lives – regardless of where they were born or live – and continue to contribute to society.”
“We welcome this collective initiative and look forward to the next steps, after the launch of the EACH. For the FH Europe community is a Technical Meeting on Paediatric FH screening, on Monday, 11th October 2021. This accompanying event of the Slovenian EU Presidency is evidence of the joint commitment to preventing premature CVD through early screening and detection of inherited risk factors.” – said Magdalena Daccord, Chief Executive of FH Europe.
 World Health Organization Fact Sheets: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
 ESC Cardiovascular Realities 2020
 ESC-EHN, Fighting Cardiovascular Disease: a blueprint for EU action: https://www.mepheartgroup.eu/wp-content/uploads/05748-CVD-plan_FINAL.pdf
FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt